Cargando…
Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL
• Secondary Malignant Histiocytosis (SMH) is an exceedingly rare, life-threatening condition that invariably occurs in the presence of an underlying monoclonal hematologic disorder. Prognosis of SMH remains dismal and there is no established treatment. • We report a case of a patient who developed S...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726878/ https://www.ncbi.nlm.nih.gov/pubmed/29264111 http://dx.doi.org/10.1016/j.lrr.2017.11.003 |